December 27, 2014 4:11 PM ET

Pharmaceuticals

Company Overview of PediatRx, Inc.

Company Overview

PediatRx, Inc., a specialty pharmaceutical company, acquires, develops, and commercializes specialty pharmaceutical products to healthcare professionals. It offers GRANISOL, an oral solution for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy. The company was incorporated in 2010 and is based in Califon, New Jersey. PediatRx, Inc. operates as a subsidiary of Striker Energy Corp.

405 Trimmer Road

Suite 200

Califon, NJ 07830

United States

Founded in 2010

Phone:

908-672-9908

Key Executives for PediatRx, Inc.

Founder
Age: 53
Chief Financial & Administrative Officer
Age: 58
Chief Commercial Officer and Vice President
Age: 50
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Janson Beckett Cosmeceuticals, Inc United States
CGI Pharmaceuticals, Inc. United States
Pfizer Centre Source United States
Morphochem, Inc. United States
Immunologic Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PediatRx, Inc., please visit www.pediatrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.